What ag, fabrikation pharmazeutischer und chemischer produkte does

Amino AG is a private Swiss pharmaceutical manufacturer founded in 1946 and operated in its second generation by the founding family. The company specializes in the development and production of sterile injectable preparations (Injectabilia), with a primary focus on analgesics and local anesthetics for the medical and hospital supply chain. It also manufactures a broader range of dosage forms including tablets, ointments, suppositories, and topical emulsions, with both Rx and OTC products in its proprietary portfolio.

The company's production infrastructure spans two Swiss sites — a modern Gebenstorf (Aargau) facility commissioned in 2007 with GMP Class A through D cleanrooms and a high-speed ampoule filling line capable of up to 250 ampoules per minute, and a secondary Belp (Bern) facility. Production capacity includes over 10 million tablets annually alongside diverse galenic forms. In-house quality control laboratories provide analytical and microbiological testing, method development and validation, stability studies, and sterility testing. The company maintains GMP certification at both sites, ISO 13485:2016 certification at Belp, a narcotics manufacturing license valid through end-2028, and is regularly inspected by Swissmedic.

Amino AG operates a dual revenue model. The first stream is the sale of its own branded pharmaceutical products to hospitals, doctors, and pharmacies. The second is contract manufacturing (Lohnherstellung) for pharmaceutical companies and hospital pharmacies, covering production, regulatory support, raw material procurement, analytical services, stability studies, packaging, and logistics across liquid, solid, and semi-solid dosage forms. With 40 employees distributed across production, quality assurance, quality control, regulatory affairs, galenic R&D, and sales/marketing, Amino AG positions itself as a flexible, specialized Swiss manufacturer serving the domestic and broader European pharmaceutical market.

Name

ag, fabrikation pharmazeutischer und chemischer produkte

Legal name

Amino AG, Fabrikation pharmazeutischer und chemischer Erzeugnisse

Website

https://amino.ch

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

1–10 employees

Short description

Amino AG is a family-owned Swiss pharmaceutical manufacturer founded in 1946 that develops and produces sterile injectable preparations and a broader range of galenic dosage forms, serving hospitals, hospital pharmacies, and pharmaceutical companies through proprietary products and contract manufacturing.

Ownership category

akta.pro rank

Product category

Sterile Injectable Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Sterile Injectable Generics (HLAIABAC)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Sterile injectable manufacturing
• Pharmaceutical contract manufacturing
• GMP-certified drug production
• Aseptic pharmaceutical manufacturing
• Hospital pharmaceutical supply

Headquarters

HQ city

Gebenstorf

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales, Others

Revenue model

1. Own Pharmaceutical Products: Manufacturing and sale of proprietary Rx medications (primarily analgesics and local anesthetics as parenteralia) and OTC medications (oral products and emulsions for topical application). Products include injectables, tablets, ointments, and suppositories.
2. Contract Manufacturing (Lohnherstellung): Full-service contract manufacturing for pharmaceutical companies and hospital pharmacies. Services include production through final analysis, regulatory support, raw material and packaging material procurement, analytical services, and finished product logistics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Amino AG manufactures sterile injectable pharmaceuticals in ampoules, vials, syringes, and bottles at two GMP-certified Swiss sites, producing both its own branded prescription and specialty OTC products (e.g., Oxytocin Amino, Metamizol Amino, Mephentermine Amino, Furosemide Amino) and offering contract manufacturing (Lohnherstellung) services to other pharmaceutical companies. The company also develops its own pharmaceutical specialties (Spezialitäten) and produces a range of complementary galenic forms including tablets, capsules, sterile liquids, and ointments.

Product overview

Amino AG is a private Swiss pharmaceutical company specializing in the development and manufacture of sterile preparations, primarily injectables. The company operates two production facilities in Gebenstorf (AG) and Belp (BE). The product portfolio consists of two main segments: (1) Own-brand pharmaceutical products including Parenteralia—predominantly analgesics and local anesthetics in various concentrations and ampoule sizes—plus OTC medications such as oral formulations and topical emulsions; and (2) Contract manufacturing services (Lohnherstellung) offering comprehensive pharmaceutical production from production through final analysis, supporting diverse galenic forms including liquids, solids, and semi-solids, with analytical services and regulatory support.

Differentiator

Problem solved

Functional benefit

Products and services

• Sterile injectable contract manufacturing (Lohnherstellung / CDMO) Contract manufacturing of sterile injectable pharmaceuticals (ampoules, vials, syringes, bottles) for other pharmaceutical companies under the client's own marketing authorization. Includes technology transfer, galenic development, aseptic filling in GMP Class A-D cleanrooms, and in-house analytical and microbiological quality control.
• Own-brand sterile injectable pharmaceutical specialties Sale of Swissmedic-authorized sterile injectable products in ampoules, vials, syringes and bottles (e.g., Oxytocin Amino, Mephentermine Amino, Metamizol Amino, Furosemide Amino, Glucose, Sodium Chloride, water for injection) to hospitals and hospital pharmacies for direct clinical use.
• Spezialitäten (own-developed pharmaceutical specialties) In-house developed pharmaceutical specialty products (Spezialitäten) sold under the Amino brand, including selected OTC specialties such as amino acid-containing specialties, alongside prescription sterile injectables.
• Non-sterile galenic forms contract manufacturing (tablets, capsules, sterile liquids, ointments) Contract manufacturing of additional galenic dosage forms — tablets, capsules, sterile liquids and ointments — for third-party pharmaceutical companies, complementing the core sterile injectable CDMO offering.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Siegfried Holding: Swiss-headquartered pharmaceutical CDMO offering API and sterile injectable manufacturing services to pharma companies, with GMP-certified facilities and broad galenic capabilities. Directly comparable as a Switzerland-based pharmaceutical contract manufacturer with injectable expertise.
• Hänseler AG: Swiss pharmaceutical manufacturer producing sterile injectables, galenic formulations, and active pharmaceutical ingredients. Comparable as a Switzerland-based pharmaceutical manufacturer with similar injectable expertise and product range.

Emerging players

• Recipharm: European pharmaceutical CDMO offering contract manufacturing services for sterile injectables, oral solids, and other dosage forms. Comparable as a contract manufacturer for injectable products, though at larger scale across multiple geographies.
• Carbogen Amcis: Swiss-based pharmaceutical CDMO specializing in API development and manufacturing, with injectable capabilities. Comparable as a Switzerland-headquartered pharmaceutical contract manufacturer with GMP-certified facilities.
• Helsinn Healthcare: Swiss specialty pharmaceutical company focused on oncology and sterile injectable products for hospital use. Comparable as a Switzerland-based pharmaceutical manufacturer producing hospital injectables with regulatory expertise.
• Aenova Holding: European pharmaceutical CDMO providing contract manufacturing for solid, semi-solid, and sterile liquid dosage forms. Comparable as a contract manufacturer offering multiple galenic forms with sterile injectable capabilities.

Broad incumbents

• B. Braun Medical: Global medical device and pharmaceutical company specializing in sterile injectable solutions, infusion therapy, and hospital products. Comparable as a manufacturer of sterile injectables serving hospitals, though at significantly larger scale and broader portfolio.
• Fresenius Kabi: Large-scale manufacturer of injectable pharmaceuticals, infusion solutions, and clinical nutrition products for hospitals worldwide. Comparable as a sterile injectable producer serving hospital pharmacies, though serving a much broader product portfolio and geographic footprint.
• Schwarz Pharma (now part of UCB): Legacy German specialty pharmaceutical manufacturer with expertise in sterile injectables and hospital products, now part of UCB. Comparable as a sterile injectable producer serving European hospital markets.

Regional players

• Dr. Heinz Welti AG: Swiss pharmaceutical manufacturer based in Bubendorf, BL, identified in Amino AG's filings as its sister company. Operates in the same Swiss pharmaceutical manufacturing space with comparable regulatory certifications and product portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/amino-ag-pharmazeutische-produkte

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ag, fabrikation pharmazeutischer und chemischer produkte